YOU ARE EXPLORING
Amy E. Krambeck, MD
Michael O. Koch Professor of Urology
Dr. Amy Krambeck is the Michael O. Koch Professor of Urology at Indiana University School of Medicine. Her Medical School training was completed at the University of Missouri-Columbia School of Medicine where she received the Janet M. Glascow award, which is awarded to any woman who graduates as Valedictorian of their Medical School class. Dr. Krambeck went on to complete her urology residency at the Mayo Clinic in Rochester, Minnesota in 2008. She subsequently, completed an endourology fellowship at the Methodist Institute for Kidney Stone Research in Indianapolis, Indiana. From 2009 to 2016 she worked as an endourologist in the Mayo Clinic Department of Urology and recently joined the staff at IU Health Physicians/Indiana University in July of 2016. Dr. Krambeck specializes in the surgical and medical treatment of stone disease and benign prostatic hyperplasia (BPH).
Methodist MPC 220 UROL
Dr. Krambeck’s research focuses on the pathogenesis, treatment and prevention of stone disease and the treatment of BPH. Since 2008 Dr. Krambeck has received funding from the National Institute of Health as part of the Mayo Clinic O’Brien Research grant to study renal precursor lesions contributing to kidney stone formation. At Indiana University she continues her close collaboration with Mayo Clinic to continue her pathogenesis research. As a member of the Endourologic Disease focused Group for Excellence (EDGE), Dr. Krambeck also participates in several national research studies analyzing optimal surgical equipment, techniques and protocols for the treatment of stone disease. Dr. Krambeck has also published extensively on the management of stone disease during pregnancy and has worked to improve treatment options for such patients. In the area of BPH, Dr. Krambeck has a special interest in the treatment of enlarged prostates in the setting of myogenic or weakened bladders. Much of her BPH research focuses on the use of Holmium Laser Enucleation of the Prostate (HoLEP) for the treatment of symptomatic lower urinary tract symptoms.